Want to see MCRB full AI Analyst Report?
Seres Therapeutics (MCRB) Income Statement
Seres Therapeutics Income Statement
Last quarter (Q2 2026), Seres Therapeutics's total revenue was $736.00K. In Q2, Seres Therapeutics's net income was $4.58M. See Seres Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 789.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 144.93M | |
| $ -3.34M | $ -3.53M | $ -19.34M | $ 0.00 | $ 144.93M | |
| $ 90.63M | $ 117.78M | $ 175.76M | $ 179.91M | $ 209.42M | |
| Depreciation and Amortization | $ 4.13M | $ 5.47M | $ 6.24M | $ 6.63M | $ 5.95M |
| $ 9.83M | $ -120.30M | $ -181.42M | $ -170.93M | $ -56.72M | |
| $ -93.97M | $ -121.31M | $ -195.10M | $ -179.91M | $ -64.49M | |
| $ 99.67M | $ -4.46M | $ 4.97M | $ -3.67M | $ -1.08M | |
| $ 5.70M | $ -125.77M | $ -190.13M | $ -183.58M | $ -65.58M | |
| $ 5.70M | $ -146.57M | $ -113.72M | $ -250.16M | $ -65.58M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.64 | $ -18.86 | $ -17.77 | $ -46.29 | $ -14.30 |
| Diluted EPS | $ 0.64 | $ -18.86 | $ -17.77 | $ -46.29 | $ -14.30 |
| Weighted Average Shares Outstanding | 8.86M | 7.77M | 6.40M | 5.40M | 4.59M |
| Weighted Average Shares Outstanding (Diluted) | 8.87M | 7.77M | 6.40M | 5.40M | 4.59M |
Currency in USD